GSK, which developed and sold versions of the now-discontinued blockbuster heartburn drug, agreed to pay up to $2.2 billion.
Related Posts
World Bank Forecast Underscores Cost of U.S. Trade War
Along with a sharply downgraded projection for global output this year, it urged a “course correction” on trade to help preserve living standards.
What’s Behind Trump’s Love-Hate Relationship With Canada
Canada is one of the United States’ largest trading partners, but President Trump wants to either take it or leave it.
Amazon Plans $1 Million Donation to Trump’s Inaugural Fund
The move follows Meta’s donation of the same amount to the fund earlier this week.